What Are the Extragastric Manifestations of H pylori Infection?
Joseph J. Jennings, MD, and Cynthia L. Sears, MD, describe the systemic effects of H pylori infection and clinical approaches for treating the extragastric complications.
Joseph J. Jennings, MD, and Cynthia L. Sears, MD, describe the systemic effects of H pylori infection and clinical approaches for treating the extragastric complications.
Researchers conducted a study to evaluate the relationship between the composition and diversity of the gut microbiome and secretor status among patients with acute gastroenteritis due to norovirus infection.
Investigators assessed the prevalence of and factors associated with Helicobacter pylori infection in children across the globe.
Investigators assessed the prevalence of postinfectious irritable bowel syndrome following Clostridioides difficile infection.
Investigators assessed the efficacy of eradication therapy for the treatment of patients with H pylori-positive functional dyspepsia.
Investigators assessed the incidence and outcomes of post-transplant Clostridioides difficile infection in patients receiving solid organ transplants.
Investigators assessed the relationship between alcohol consumption and risk for Helicobacter pylori infection.
Investigators analyzed the distribution of microbial pathogens identified from stool gastrointestinal polymerase chain reaction testing in patients who ultimately developed IBD.
Given the overall prevalence of irritable bowel syndrome, it is important for clinicians to be able to distinguish postinfectious irritable bowel syndrome from its other subtypes.
Investigators evaluated the potential effects of antibiotic treatment on immunogenicity to anti-TNF agents among patients with IBD.